Rocket Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript
Thank you, everyone. My name is Gena Wang. I'm SMid-Cap biotech analyst at Barclays. I first hope everyone stay healthy, and I would like to thank all the participants, the investors, companies and especially our event team and corporate access team, who made this virtual health care conference possible.
With that, I would like to introduce our next speaker, Gaurav Shah, President and CEO from Rocket. Gaurav, I will hand over to you.
Hi, Gena. Thank you, and thank you for continuing to host this webcast despite the travel restrictions. And I also hope everyone stays healthy and safe in the days to come. So I will spend a few minutes talking through an overview of Rocket. And then, I think, Gena, you and I can go back and forth on Q&A.
So this is the decade of gene therapy. We're very excited about the prospect of being a part of that evolving gene therapy story for curative medicines for really
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |